Follow
Elisabeth Letellier
Title
Cited by
Cited by
Year
Yes and PI3K bind CD95 to signal invasion of glioblastoma
S Kleber, I Sancho-Martinez, B Wiestler, A Beisel, C Gieffers, O Hill, ...
Cancer cell 13 (3), 235-248, 2008
3372008
In search of definitions: Cancer‐associated fibroblasts and their markers
M Nurmik, P Ullmann, F Rodriguez, S Haan, E Letellier
International journal of cancer 146 (4), 895-905, 2020
2182020
The TNF family of ligands and receptors: communication modules in the immune system and beyond
C Dostert, M Grusdat, E Letellier, D Brenner
Physiological reviews 99 (1), 115-160, 2019
1862019
The death receptor CD95 activates adult neural stem cells for working memory formation and brain repair
NS Corsini, I Sancho-Martinez, S Laudenklos, D Glagow, S Kumar, ...
Cell stem cell 5 (2), 178-190, 2009
1352009
CD95-ligand on peripheral myeloid cells activates Syk kinase to trigger their recruitment to the inflammatory site
E Letellier, S Kumar, I Sancho-Martinez, S Krauth, A Funke-Kaiser, ...
Immunity 32 (2), 240-252, 2010
1302010
Microbiome in colorectal cancer: how to get from meta-omics to mechanism?
D Ternes, J Karta, M Tsenkova, P Wilmes, S Haan, E Letellier
Trends in microbiology 28 (5), 401-423, 2020
862020
Prognostic and predictive molecular biomarkers for colorectal cancer: updates and challenges
E Koncina, S Haan, S Rauh, E Letellier
Cancers 12 (2), 319, 2020
852020
Hypoxia-induced autophagy drives colorectal cancer initiation and progression by activating the PRKC/PKC-EZR (ezrin) pathway
K Qureshi-Baig, D Kuhn, E Viry, VI Pozdeev, M Schmitz, F Rodriguez, ...
Autophagy 16 (8), 1436-1452, 2020
702020
Tumor-Initiating Cells: a criTICal review of isolation approaches and new challenges in targeting strategies
K Qureshi-Baig, P Ullmann, S Haan, E Letellier
Molecular cancer 16 (1), 1-16, 2017
672017
SOCS2: physiological and pathological functions
E Letellier, S Haan
Frontiers in Bioscience-Elite 8 (1), 189-204, 2016
642016
Identification of SOCS2 and SOCS6 as biomarkers in human colorectal cancer
E Letellier, M Schmitz, K Baig, N Beaume, C Schwartz, S Frasquilho, ...
British journal of cancer 111 (4), 726-735, 2014
622014
The hematopoietic factor granulocyte‐colony stimulating factor improves outcome in experimental spinal cord injury
C Pitzer, S Klussmann, C Krüger, E Letellier, C Plaas, T Dittgen, F Kirsch, ...
Journal of neurochemistry 113 (4), 930-942, 2010
612010
What do we learn from spheroid culture systems? Insights from tumorspheres derived from primary colon cancer tissue
K Qureshi-Baig, P Ullmann, F Rodriguez, S Frasquilho, PV Nazarov, ...
PloS one 11 (1), e0146052, 2016
522016
A new ALK isoform transported by extracellular vesicles confers drug resistance to melanoma cells
G Cesi, D Philippidou, I Kozar, YJ Kim, F Bernardin, G Van Niel, ...
Molecular cancer 17 (1), 1-14, 2018
472018
Manganese‐enhanced magnetic resonance imaging for in vivo assessment of damage and functional improvement following spinal cord injury in mice
B Stieltjes, S Klussmann, M Bock, R Umathum, J Mangalathu, E Letellier, ...
Magnetic Resonance in Medicine: An Official Journal of the International …, 2006
472006
Hypoxia-responsive miR-210 promotes self-renewal capacity of colon tumor-initiating cells by repressing ISCU and by inducing lactate production
P Ullmann, K Qureshi-Baig, F Rodriguez, A Ginolhac, Y Nonnenmacher, ...
Oncotarget 7 (40), 65454, 2016
462016
Integrated in vitro and in silico modeling delineates the molecular effects of a synbiotic regimen on colorectal-cancer-derived cells
K Greenhalgh, J Ramiro-Garcia, A Heinken, P Ullmann, T Bintener, ...
Cell reports 27 (5), 1621-1632. e9, 2019
452019
Loss of Myosin Vb in colorectal cancer is a strong prognostic factor for disease recurrence
E Letellier, M Schmitz, A Ginolhac, F Rodriguez, P Ullmann, ...
British journal of cancer 117 (11), 1689-1701, 2017
422017
Tumor suppressor miR-215 counteracts hypoxia-induced colon cancer stem cell activity
P Ullmann, M Nurmik, M Schmitz, F Rodriguez, J Weiler, K Qureshi-Baig, ...
Cancer Letters 450, 32-41, 2019
402019
Identifying and targeting cancer-specific metabolism with network-based drug target prediction
MP Pacheco, T Bintener, D Ternes, D Kulms, S Haan, E Letellier, T Sauter
EBioMedicine 43, 98-106, 2019
362019
The system can't perform the operation now. Try again later.
Articles 1–20